HTKP Injects Power: 16 Crore API Project Fortifies India's Pharma Shield

HTKP Industries Private Limited is gearing up to fortify India's pharmaceutical sector with its Active Pharmaceutical Ingredients (API) project in the GIDC Industrial Estate, Ankleshwar, Bharuch, Gujarat. With a substantial investment of 16 crores, this venture is poised to churn out an impressive 107.1 tons of API per month. The strategic location in Ankleshwar, renowned as a pharmaceutical hub, ensures seamless integration into the industry's supply chain and access to crucial resources and expertise.

This API project by HTKP Industries is poised to make a substantial contribution to India's self-sufficiency in pharmaceutical manufacturing, thereby reducing reliance on imports and bolstering the nation's position as a global pharmaceutical powerhouse. By locally producing high-quality API, the project enhances supply chain resilience, mitigates risks, and fosters innovation and competitiveness in the industry.

Aligned with the government's agenda of promoting indigenous manufacturing and innovation in the pharmaceutical sector, HTKP Industries' initiative resonates with flagship programs such as "Make in India" and "Pharma Vision 2020." Leveraging advanced technology and adhering to stringent quality standards, the company aims to deliver API products that meet international regulatory requirements and cater to diverse therapeutic needs.

HTKP Industries is steadfast in its commitment to sustainability and environmental stewardship throughout its manufacturing processes. Through efficient resource utilization, waste minimization, and compliance with environmental regulations, the company endeavors to reduce its ecological footprint and uphold responsible production practices.

News by Rahul Yelligetti